STRATUMfiling intelligence๐Ÿ‡ฎ๐Ÿ‡ณ Indian private portal

CIK 1946399

LakeShore Biopharma Co., Ltd
CIK 0001946399 ยท EDGAR โ†—
cleanelevatedtriggeredno dataplanned
74.2
composite ยท 3 signals ยท TRIGGERED

Every card below shows the score and the exact filing data it was computed from โ€” no unexplained numbers. Some signals (P-02, P-03, P-08, P-09, P-10, P-11) pull live documents from SEC EDGAR the first time you view this company; a few of those (P-03, P-10, P-11) use AI to read the filing text, but every AI claim must quote the actual document verbatim or it's discarded โ€” never a guess.

Chat with this filing โ†’

Ask follow-up questions about the latest 10-K, with citations verified against the actual text. No account needed.

Investigation memo โ€” generate one โ†’

Run the bounded investigation agent โ€” reads this company's signals and writes a short, cited summary.

Signals

P-13 ยท FY 2025-03-31 ยท TRIGGERED93.0

Zombie / distress

Zombie: interest coverage below 1.0x for 3 consecutive years
trend: flat
Trend
Source: 20-F on SEC.gov (filed 2025-07-31) โ†—
Evidence โ€” inputs and thresholds
{
  "icr_by_year": {
    "2025-03-31": -0.72,
    "2024-03-31": -1.323,
    "2023-03-31": -0.634
  },
  "consecutive_years_below_1": 3,
  "altman_z_double_prime": -5.474,
  "definitions": {
    "zombie": "ICR<1 for 3+ consecutive FYs (BIS 2018)",
    "z_distress": "<1.1 distress, 1.1-2.6 gray, >2.6 safe"
  },
  "inputs": {
    "ebit_t": -12021382,
    "interest_expense_t": 16700000
  },
  "stale": false,
  "latest_filing_period": "2025-03-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1946399/000121390025069880/0001213900-25-069880-index.htm",
    "form": "20-F",
    "filed": "2025-07-31"
  }
}
P-01 ยท FY 2025-03-31 ยท CLEAN32.9

Earnings quality

Beneish M-Score -2.37 โ€” no manipulation profile
trend: flat
Trend
Source: 20-F on SEC.gov (filed 2025-07-31) โ†—
Evidence โ€” inputs and thresholds
{
  "m_score": -2.373,
  "threshold": -1.78,
  "ratios": {
    "DSRI": 1.052,
    "GMI": 0.964,
    "AQI": 0.907,
    "SGI": 1.06,
    "DEPI": 1.037,
    "SGAI": 1,
    "LVGI": 1.041,
    "TATA": 0.015
  },
  "defaulted_to_neutral": [
    "SGAI"
  ],
  "sloan_accruals": 0.0145,
  "inputs": {
    "revenue_t": 85670723,
    "revenue_t1": 80820050,
    "total_assets_t": 190530106,
    "net_income_t": -13928624,
    "cfo_t": -16854048
  },
  "stale": false,
  "latest_filing_period": "2025-03-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1946399/000121390025069880/0001213900-25-069880-index.htm",
    "form": "20-F",
    "filed": "2025-07-31"
  }
}
P-12 ยท FY 2025-03-31 ยท CLEAN12.3

Restatement predictor

F-Score 0.37 โ€” at or below the population base rate
trend: flat
Trend
Source: 20-F on SEC.gov (filed 2025-07-31) โ†—
Evidence โ€” inputs and thresholds
{
  "f_score": 0.368,
  "probability": 0.00136,
  "components": {
    "rsst": 0.0145,
    "drec": 0.0356,
    "dinv": 0.015,
    "soft": 0.6977,
    "dcs": -0.0288,
    "droa": 0.2134,
    "issue": 0
  },
  "model": "Dechow et al. 2011, Model 1 (simplified RSST)",
  "thresholds": {
    "elevated": 1,
    "triggered": 1.85
  },
  "stale": false,
  "latest_filing_period": "2025-03-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1946399/000121390025069880/0001213900-25-069880-index.htm",
    "form": "20-F",
    "filed": "2025-07-31"
  }
}